Biphasic HA dermal fillers are characterized by
1.adding of non cross linked HA
-non cross linked HA disappear in 1-2wks
2.big particle size
3.relatively short duration
4.low cross linking ratio
5.easy to mold shape
Monophasic HA dermal fillers are characterized by
1.non adding of non cross linked HA
2.longer duration
3.relatively high duration
4 .difficult to mold shape
5.relatively high cross linking ratio
GANA HA is characterized by
1.non adding of non cross linked HA
2.highest cross linking ratio
3.highest HA concentration
4.GANA HA has small particle size so that doctors are easy to make shape
5.highest viscosity than any other dermal fillers
6.longest duration
7.low extruding force
GANA HA VS existing fillers
Monophasic (ex.Juvederm) | Biphasic (ex.restylane) | GANA HA | |
Cross linking ratio % | 6-8% | 2-4% | 10% |
HA concentration (mg/cc) | 20-24 | 20-24 | 20-24 |
Cross linking agent | BDDE | BDDE | BDDE |
Durarion month | 6-12 | 6-18 | 12-18 |
Particle size | None | 100-2000um | 50-100um |
Viscosity. CPS. | 2-4X 106CPS | 1-4 X106CPS | 4-7 X106CPS |
주사깊이
Recommended application of GANA HA
A type: cheek,chin,forehead , nose
B type: nasolabial fold,lips
C type: fine wrinkle, around eyes
Recommended dose
1. Nose 1-2ml
2.Nasolabial fold 2-3ml
3. Forehead 3-5ml
4.Lip each side over 1ml
5. cheek 4-10ml
6.Short chin 2-4ml
7.Sunken eye 1ml
8.Temporal area depression each
over 2ml
GANA HA type
GANA HA | volume | Injection layer | Recommended guage | Similar products | HA concentration ( mg/cc) | Cross linking ratio | Recommended use |
A type | 1.2ml | Sub Q | 25 | Restylane Sub Q | 24 | 10% | Large volume augmentation |
B type | 1.2ml | deep dermis | 27 | perlane | 22 | 10% | Moderate wrinkle |
C type | 1.2ml | dermis | 30 | touch | 20 | 10% | Fine wrinkle |
hydro | 2.5ml | eipdermis | 30 | vital | 10 | 5% | mestoherapy |
Before and after
Upper lip augmentation by GANA HA B type 1ml used